Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Febuxostat uses and benefits?Monoferric 1000 mg price?How much is epclusa treatment?Tibsovo ema approval?How much does a low fat diet improve lipitor's performance?
See the DrugPatentWatch profile for vyzulta
Vyzulta is a prescription medicine given as eye drops. It is used to lower high pressure inside the eye (intraocular pressure) in people with glaucoma or ocular hypertension, helping reduce the risk of vision damage from sustained eye-pressure elevation.
Vyzulta contains latanoprostene bunod as its active ingredient.
Vyzulta helps lower intraocular pressure by improving fluid outflow from the eye and supporting normal regulation of eye fluid dynamics, which reduces pressure over time.
It’s typically prescribed for adults who need ongoing eye-pressure control due to glaucoma or ocular hypertension.
Vyzulta is administered as eye drops on a regular schedule as directed by a clinician. Patients should follow their prescriber’s dosing instructions and avoid changing the schedule without medical advice.
For updates related to patents and exclusivity, DrugPatentWatch.com tracks Vyzulta-related filings: https://www.drugpatentwatch.com/
Other Questions About Vyzulta :